All Stories

  1. Vaccine-preventable HPV burden and cervical abnormalities in women during 2022–2024 Octobre Rose campaigns in Libreville

    Article • Nature Communications, December 2025, Springer Science + Business Media

    Professor Joel Fleury DJOBA SIAWAYA

  2. Congenital measles: a case highlighting challenges in clinical interventions in a developing country

    Article • International Journal of Infectious Diseases, November 2025, Elsevier

    Professor Joel Fleury DJOBA SIAWAYA

  3. Measles trend in Gabon: Insight from 18 years of surveillance data

    Article • iScience, October 2025, Elsevier

    Professor Joel Fleury DJOBA SIAWAYA

  4. Publisher Correction: Survey of the risk behaviors and mental health of adolescents in Gabon

    Article • Communications Medicine, January 2025, Springer Science + Business Media

    Professor Joel Fleury DJOBA SIAWAYA

  5. Virological Remission in Two HIV‐Infected Children After Early cART in Libreville, Gabon

    Article • Case Reports in Pediatrics, January 2025, Wiley

    Professor Joel Fleury DJOBA SIAWAYA

  6. Survey of the risk behaviors and mental health of adolescents in Gabon

    Article • Communications Medicine, November 2024, Springer Science + Business Media

    Professor Joel Fleury DJOBA SIAWAYA

  7. Pediatric tuberculosis in a high burden setting: Socio-spatial distribution, blood elements features, and outcomes

    Article • Heliyon, July 2024, Elsevier

    Professor Joel Fleury DJOBA SIAWAYA

  8. HIV-exposed uninfected infants’ immune defects: From pathogen sensing, oxidative burst to antigens responses

    Article • iScience, December 2023, Elsevier

    Professor Joel Fleury DJOBA SIAWAYA

  9. Corrigendum: Microbiology laboratories involved in disease and antimicrobial resistance surveillance: Strengths and challenges of the central African states

    Article • African Journal of Laboratory Medicine, May 2023, AOSIS Open Journals

    Professor Joel Fleury DJOBA SIAWAYA

  10. Changes of C-reactive protein and Procalcitonin after four weeks of treatment in patients with pulmonary TB

    Article • Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, May 2023, Elsevier

    Professor Joel Fleury DJOBA SIAWAYA

  11. Prostate malignant tumor and benign prostatic hyperplasia microenvironments in black African men: Limited infiltration of CD8+ T lymphocytes, NK‐cells, and high frequency of CD73+ stromal cells

    Article • Cancer Reports, April 2023, Wiley

    Professor Joel Fleury DJOBA SIAWAYA

  12. Allergen sensitization and polysensitization pattern of adults and children in an urban Sub-Saharan African setting (Libreville, Gabon)

    Article • Journal of Allergy and Clinical Immunology Global, February 2023, Elsevier

    Professor Joel Fleury DJOBA SIAWAYA

  13. Vitamin D2 versus vitamin D3 as a risk factor in compromised bone health

    Article • The Moldovan Medical Journal, December 2022, State Enterprise "Revista Curier Medical"

    Professor Joel Fleury DJOBA SIAWAYA

  14. Outcomes of severe malaria and its clinical features in Gabonese children

    Article • Frontiers in Tropical Diseases, September 2022, Frontiers

    Professor Joel Fleury DJOBA SIAWAYA

  15. Malaria beyond its predominant endemic regions: Emerging threat or sporadic events?

    Article • Frontiers in Medicine, September 2022, Frontiers

    Professor Joel Fleury DJOBA SIAWAYA

  16. Microbiology laboratories involved in disease and antimicrobial resistance surveillance: Strengths and challenges of the central African states

    Article • African Journal of Laboratory Medicine, March 2022, AOSIS Open Journals

    Professor Joel Fleury DJOBA SIAWAYA

  17. Mapping Allergic Diseases in Sub-Saharan Africa

    Article • Frontiers in Allergy, February 2022, Frontiers

    Professor Joel Fleury DJOBA SIAWAYA

  18. Creatine kinase-(MB) and hepcidin as candidate biomarkers for early diagnosis of pulmonary tuberculosis: a proof-of-concept study in Lambaréné, Gabon

    Article • Infection, February 2022, Springer Science + Business Media

    Professor Joel Fleury DJOBA SIAWAYA

  19. Emergence of B.1.1.318 SARS-CoV-2 viral lineage and high incidence of alpha B.1.1.7 variant of concern in the Republic of Gabon

    Article • International Journal of Infectious Diseases, January 2022, Elsevier

    Professor Joel Fleury DJOBA SIAWAYA

  20. SARS-CoV-2 emerging variants in Africa: view from Gabon

    Article • The Lancet Microbe, August 2021, Elsevier

    Professor Joel Fleury DJOBA SIAWAYA

  21. Unrecognized introduction of SARS‐CoV‐2 variants of concern to Central Africa: Import and local transmission of B.1.1.7 in Gabon in the very early stage of the variant spread to the African continent

    Article • Journal of Medical Virology, July 2021, Wiley

    Professor Joel Fleury DJOBA SIAWAYA

  22. Profiles of microorganisms isolated from neonates’ blood cultures, incubators, cradles, ventilators, washbasins, and health-workers of Libreville University Hospital Neonatal Service: focus on infection prevention and control measures

    Article • Journal of Public Health in Africa, June 2021, AOSIS Open Journals

    Professor Joel Fleury DJOBA SIAWAYA

  23. Dynamic and features of SARS-CoV-2 infection in Gabon

    Article • Scientific Reports, May 2021, Springer Science + Business Media

    Professor Joel Fleury DJOBA SIAWAYA

  24. Circulating anti-SARS-CoV-2 nucleocapsid (N)-protein antibodies and anti-SARS-CoV-2 spike (S)-protein antibodies in an African setting: herd immunity, not there yet!

    Article • BMC Research Notes, April 2021, Springer Science + Business Media

    Professor Joel Fleury DJOBA SIAWAYA

  25. Case series of SARS‐COV‐2 infection in pregnant African women: focus on biological features

    Article • Journal of Medical Virology, March 2021, Wiley

    Professor Joel Fleury DJOBA SIAWAYA

  26. Higher IL-8 Response to <i>Mycobacterium tuberculosis</i> Antigens in Women above 40 Years

    Article • Journal of Tuberculosis Research, January 2021, Scientific Research Publishing, Inc,

    Professor Joel Fleury DJOBA SIAWAYA

  27. Evidence and implications of pre‐existing humoral cross‐reactive immunity to SARS‐CoV‐2

    Article • Immunity Inflammation and Disease, December 2020, Wiley

    Professor Joel Fleury DJOBA SIAWAYA

  28. Escalating and sustained immunovirological dissociation among antiretroviral drug-experienced perinatally human immunodeficiency virus-1-infected children and adolescents living in the Central African Republic

    Article • Medicine, May 2020, Wolters Kluwer Health

    Professor Joel Fleury DJOBA SIAWAYA

  29. Purifying Selection in Human Immunodeficiency Virus-1 pol Gene in Perinatally Human Immunodeficiency Virus-1-Infected Children Harboring Discordant Immunological Response and Virological Nonresponse to Long-Term Antiretroviral Therapy

    Article • Journal of Clinical Medicine Research, January 2020, Elmer Press, Inc.

    Professor Joel Fleury DJOBA SIAWAYA

  30. Increased platelets count in HIV-1 uninfected infants born from HIV-1 infected mothers

    Article • Hematology Reports, September 2019, MDPI AG

    Professor Joel Fleury DJOBA SIAWAYA

  31. M. tuberculosis infection and antigen specific cytokine response in healthcare workers frequently exposed to tuberculosis

    Article • Scientific Reports, June 2019, Springer Science + Business Media

    Professor Joel Fleury DJOBA SIAWAYA

  32. HIV-exposed uninfected compared with unexposed infants show the presence of leucocytes, lower lactoferrin levels and antimicrobial-resistant micro-organisms in the stool

    Article • Paediatrics and International Child Health, February 2019, Taylor & Francis

    Professor Joel Fleury DJOBA SIAWAYA, Moungoyi Massala Mouima Rebecka Emmanuelle Ruth

  33. Global variation in bacterial strains that cause tuberculosis disease: a systematic review and meta-analysis

    Article • BMC Medicine, October 2018, Springer Science + Business Media

    Professor Joel Fleury DJOBA SIAWAYA

  34. Altered Toll-Like Receptor-4 Response to Lipopolysaccharides in Infants Exposed to HIV-1 and Its Preventive Therapy

    Article • Frontiers in Immunology, February 2018, Frontiers

    Professor Joel Fleury DJOBA SIAWAYA

  35. Mother-to-child HIV-transmission prevention programs in a sub-Saharan African setting: The Gabonese experience

    Article • International Journal of STD & AIDS, July 2017, SAGE Publications

    Professor Joel Fleury DJOBA SIAWAYA

  36. Use of GeneXpert Remnants for Drug Resistance Profiling and Molecular Epidemiology of Tuberculosis in Libreville, Gabon

    Article • Journal of Clinical Microbiology, April 2017, ASM Journals

    Professor Joel Fleury DJOBA SIAWAYA

  37. Cases of Impaired Oxidative Burst in HIV-Exposed Uninfected Infants’ Neutrophils—A Pilot Study

    Article • Frontiers in Immunology, March 2017, Frontiers

    Professor Joel Fleury DJOBA SIAWAYA

  38. Metabolic Deregulation Associated with Glycemic Imbalance In Gabonese Diabetics

    Article • Diabetes Case Reports, January 2017, OMICS Publishing Group

    Professor Joel Fleury DJOBA SIAWAYA

  39. Phytochemical screening, antioxidant and antimicrobial potential of stem barks of Coula edulis Baill. Pseudospondias longifolia Engl. and Carapa klaineana Pierre. from Gabon

    Article • Asian Pacific Journal of Tropical Disease, July 2016, Elsevier

    Professor Joel Fleury DJOBA SIAWAYA

  40. Hepatitis C virus seroprevalence in adults in Africa: a systematic review and meta-analysis

    Article • October 2015, Wiley

    Professor Joel Fleury DJOBA SIAWAYA

  41. Pyrazinamide resistance in Mycobacterium tuberculosis arises after rifampicin and fluoroquinolone resistance

    Article • The International Journal of Tuberculosis and Lung Disease, June 2015, International Union Against Tuberculosis and Lung Disease

    Professor Joel Fleury DJOBA SIAWAYA

  42. HIV, HBS, HCV, HTLV and syphilis prevalence among high school learners and university student in Libreville, Gabon

    Article • Vulnerable Children and Youth Studies, April 2015, Taylor & Francis

    Professor Joel Fleury DJOBA SIAWAYA

  43. Genital Mycoplasma infections and their resistance phenotypes in an African setting

    Article • European Journal of Clinical Microbiology & Infectious Diseases, January 2015, Springer Science + Business Media

    Professor Joel Fleury DJOBA SIAWAYA

  44. Blood Transfusion, Serum Ferritin, and Iron in Hemodialysis Patients in Africa

    Article • Journal of Blood Transfusion, January 2015, Hindawi Publishing Corporation

    Professor Joel Fleury DJOBA SIAWAYA

  45. Prevalence and Relationship between Hyperglycemia Hypertension and Obesity in Libreville-Gabon: A Pilot Study

    Article • Endocrinology & Diabetes Research, January 2015, OMICS Publishing Group

    Professor Joel Fleury DJOBA SIAWAYA

  46. Correction: Chlamydia trachomatis, Human Immunodeficiency Virus (HIV) Distribution and Sexual Behaviors across Gender and Age Group in an African Setting

    Article • PLOS One, December 2014, PLOS

    Professor Joel Fleury DJOBA SIAWAYA

  47. Antimicrobial profiles of bacterial clinical isolates from the Gabonese National Laboratory of Public Health: data from routine activity

    Article • International Journal of Infectious Diseases, December 2014, Elsevier

    Professor Joel Fleury DJOBA SIAWAYA

  48. Evaluation of blood donors questionnaire in a developing country: The case of Gabon

    Article • Transfusion Clinique et Biologique, June 2014, Elsevier

    Professor Joel Fleury DJOBA SIAWAYA

  49. Chlamydia trachomatis, Human Immunodeficiency Virus (HIV) Distribution and Sexual Behaviors across Gender and Age Group in an African Setting

    Article • PLOS One, March 2014, PLOS

    Professor Joel Fleury DJOBA SIAWAYA

  50. Oncomodulin and macrophages derived factors in pancreas injury and development paradigms

    Article • Modern Research in Inflammation, January 2013, Scientific Research Publishing, Inc,

    Professor Joel Fleury DJOBA SIAWAYA

  51. Phytochemical screening and cytotoxicity studies of Chrysophyllum pruniforme Pierre ex Engl. barks

    Article • Pharmacognosy Research, January 2013, Medknow

    Professor Joel Fleury DJOBA SIAWAYA

  52. Cytokines in Pulmonary Tuberculosis

    Article • June 2011, Taylor & Francis

    Professor Joel Fleury DJOBA SIAWAYA

  53. Biological and Toxicological Effects of Aqueous Acetone Extract of Cienfuegosia digitata Cav. (Malvaceae) in Mice and Rats

    Article • Journal of Pharmacology and Toxicology, February 2011, Science Alert

    Professor Joel Fleury DJOBA SIAWAYA

  54. Plasma cytokine levels during acute HIV-1 infection predict HIV disease progression

    Article • AIDS, March 2010, Wolters Kluwer Health

    Dr. Lisa M Bebell, Professor Joel Fleury DJOBA SIAWAYA

  55. Differential cytokine/chemokines and KL-6 profiles in patients with different forms of tuberculosis

    Article • August 2009, Elsevier

    Professor Joel Fleury DJOBA SIAWAYA

  56. Differential cytokine secretion and early treatment response in patients with pulmonary tuberculosis

    Article • Clinical & Experimental Immunology, April 2009, Wiley

    Professor Joel Fleury DJOBA SIAWAYA

  57. Molecular Markers of Infectious Diseases

    Article • Disease Markers, January 2009, Hindawi Publishing Corporation

    Professor Joel Fleury DJOBA SIAWAYA

  58. Differential Cytokine Secretion and Early Treatment Response in Patients with Pulmonary Tuberculosis

    Article • Clinical & Experimental Immunology, December 2008, Wiley

    Professor Joel Fleury DJOBA SIAWAYA

  59. Biomarkers for TB treatment response: Challenges and future strategies

    Article • Journal of Infection, August 2008, Elsevier

    Professor Joel Fleury DJOBA SIAWAYA

  60. An Evaluation of Commercial Fluorescent Bead-Based Luminex Cytokine Assays

    Article • PLOS One, July 2008, PLOS

    Professor Joel Fleury DJOBA SIAWAYA

  61. Differential Expression of Interleukin-4 (IL-4) and IL-4 2 mRNA, but Not Transforming Growth Factor Beta (TGF- ), TGF- RII, Foxp3, Gamma Interferon, T-bet, or GATA-3 mRNA, in Patients with Fast and Slow Responses to Antituberculosis Treatment

    Article • Clinical and Vaccine Immunology, June 2008, ASM Journals

    Professor Joel Fleury DJOBA SIAWAYA

  62. Immune parameters as markers of tuberculosis extent of disease and early prediction of anti-tuberculosis chemotherapy response

    Article • Journal of Infection, May 2008, Elsevier

    Professor Joel Fleury DJOBA SIAWAYA

  63. Correlates for disease progression and prognosis during concurrent HIV/TB infection

    Article • International Journal of Infectious Diseases, July 2007, Elsevier

    Professor Joel Fleury DJOBA SIAWAYA